Cargando…
Blocking the short isoform of augmenter of liver regeneration inhibits proliferation of human multiple myeloma U266 cells via the MAPK/STAT3/cell cycle signaling pathway
Multiple myeloma (MM) is the second most common haematological malignancy and remains an incurable disease, with most patients relapsing and requiring further treatment. Augmenter of liver regeneration (ALR) is a vital protein affecting fundamental processes such as energy transduction, cell surviva...
Autores principales: | Huang, Wenqi, Sun, Hang, Hu, Ting, Zhu, Dongju, Long, Xianli, Guo, Hui, Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816290/ https://www.ncbi.nlm.nih.gov/pubmed/33574936 http://dx.doi.org/10.3892/ol.2021.12458 |
Ejemplares similares
-
Silencing of augmenter of liver regeneration inhibited cell proliferation and triggered apoptosis in U266 human multiple myeloma cells
por: Zeng, H.Q., et al.
Publicado: (2017) -
In vitro comparison of the cytotoxic effects of statins on U266 myeloma cell line
por: Terzi, Hatice, et al.
Publicado: (2019) -
Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells
por: Rhee, Yun-Hee, et al.
Publicado: (2012) -
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL
por: Suzuki, Kazuhito, et al.
Publicado: (2016) -
Baicalein Inhibits Proliferation of Myeloma U266 Cells by Downregulating IKZF1 and IKZF3
por: Liu, Xiao-Ping, et al.
Publicado: (2018)